The role of cetuximab as first‐line treatment of colorectal liver metastases

The literature does not support the routine use of cetuximab as the standard first‐line treatment of colorectal liver metastases, rather highlighting the need for the optimization of treatment on an individual basis, especially depending on tumour KRAS status.